POU5F1P1, a putative cancer susceptibility gene, is overexpressed in prostatic carcinoma

Prostate

Volumn 70, Issue 6, 2010, Pages 666-674

  Kastler, Silvia ^a   Honold, Lisa ^a   Luedeke, Manuel ^a   Kuefer, Rainer ^a   Möller, Peter ^a   Hoegel, Josef ^a   Vogel, Walther ^a   Maier, Christiane ^a   Assum, Guenter ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

8q24; Cancer susceptibility; OCT4; POU5F1P1; Prostate cancer

Indexed keywords

MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR POU5F1P1; UNCLASSIFIED DRUG; POU5F1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CARCINOMA; ADENOCARCINOMA; CHROMOSOME 8; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PROSTATE TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA; AGED; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 8; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OCTAMER TRANSCRIPTION FACTOR-3; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS;

EID: 77950891289     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21100     Document Type: Article

References (25)

1. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, Sulem P, Kristjansson K, Arnason S, Gulcher JR, Bjornsson J, Kong A, Thorsteinsdottir U, Stefansson K. Cancer as a complex phenotype: Pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004;1 (3):e65. (Pubitemid 40418886)
2. Salinas CA, Kwon E, Carlson CS, Koopmeiners JS, Feng Z, Karyadi DM, Ostrander EA, Stanford JL. Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2008;17 (5):1203-1213.
3. Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S, Penegar S, Chandler I, Gorman M, Wood W, Barclay E, Lubbe S, Martin L, Sellick G, Jaeger E, Hubner R, Wild R, Rowan A, Fielding S, Howarth K, Silver A, Atkin W, Muir K, Logan R, Kerr D, Johnstone E, Sieber O, Gray R, Thomas H, Peto J, Cazier JB, Houlston R. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 2007;39 (8):984-988. (Pubitemid 47185182)
4. Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, Whittemore AS, Gayther SA, Giles GG, Guy M, Edwards SM, Morrison J, Donovan JL, Hamdy FC, Dearnaley DP, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Brown PM, Hopper JL, Neal DE, Pharoah PD, Ponder BA, Eeles RA, Easton DF, Dunning AM. Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 2008;100 (13):962-966. (Pubitemid 351957516)
5. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H, Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998;95 (3):379-391. (Pubitemid 28507326)
6. Scholer HR, Balling R, Hatzopoulos AK, Suzuki N, Gruss P. Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J 1989;8 (9):2551-2557. (Pubitemid 19273338)
7. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126 (4):663-676. (Pubitemid 44233629)
8. Zaehres H, Scholer HR. Induction of pluripotency: From mouse to human. Cell 2007;131 (5):834-835.
9. Kim JB, Sebastiano V, Wu G, Arauzo-Bravo MJ, Sasse P, Gentile L, Ko K, Ruau D, Ehrich M, van den Boom D, Meyer J, Hubner K, Bernemann C, Ortmeier C, Zenke M, Fleischmann BK, Zaehres H, Scholer HR. Oct4-Induced Pluripotency in Adult Neural Stem Cells. Cell 2009;136 (3):411-419.
10. Moller E, Stenman G, Mandahl N, Hamberg H, Molne L, van den Oord JJ, Brosjo O, Mertens F, Panagopoulos I. POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands. J Pathol 2008;215 (1):78-86. (Pubitemid 351619878)
11. Yamaguchi S, Yamazaki Y, Ishikawa Y, Kawaguchi N, Mukai H, Nakamura T. EWSR1 is fused to POU5F1 in a bone tumor with translocation T(6;22)(P21;Q12). Genes Chromosomes Cancer 2005;43 (2):217-222. (Pubitemid 40570743)
12. Santagata S, Ligon KL, Hornick JL. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Am J Surg Pathol 2007;31 (6):836-845. (Pubitemid 47165136)
13. Atlasi Y, Mowla SJ, Ziaee SA, Bahrami AR. OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 2007;120 (7):1598-1602. (Pubitemid 46355399)
14. Chang CC, Shieh GS, Wu P, Lin CC, Shiau AL, Wu CL. Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res 2008;68 (15):6281-6291.
15. Karoubi G, Gugger M, Schmid R, Dutly A. OCT4 expression in human non-small cell lung cancer: Implications for therapeutic intervention. Interact Cardiovasc Thorac Surg 2009;8 (4):393-397.
16. Seigel GM, Hackam AS, Ganguly A, Mandell LM, Gonzalez-Fernandez F. Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis 2007;13:823-832. (Pubitemid 46908324)
17. Sotomayor P, Godoy A, Smith GJ, Huss WJ. Oct4A is expressed by a subpopulation of prostate neuroendocrine cells. Prostate 2009;69 (4):401-410.
18. Cantz T, Key G, Bleidissel M, Gentile L, Han DW, Brenne A, Scholer HR. Absence of OCT4 expression in somatic tumor cell lines. Stem Cells 2008;26 (3):692-697.
19. Liedtke S, Stephan M, Kogler G. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol Chem 2008;389 (7):845-850.
20. Mueller T, Luetzkendorf J, Nerger K, Schmoll HJ, Mueller LP. Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells. Cell Mol Life Sci 2009;66 (3):495-503.
21. Suo G, Han J, Wang X, Zhang J, Zhao Y, Zhao Y, Dai J. Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun 2005;337 (4):1047-1051. (Pubitemid 41505231)
22. Panagopoulos I, Moller E, Collin A, Mertens F. The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1. Oncol Rep 2008;20 (5):1029-1033.
23. Bachmann N, Haeusler J, Luedeke M, Kuefer R, Perner S, Assum G, Paiss T, Hoegel J, Vogel W, Maier C. Expression changes of CAV1 and EZH2, located on 7q31 approximately q36, are rarely related to genomic alterations in primary prostate carcinoma. Cancer Genet Cytogenet 2008;182 (2):103-110. (Pubitemid 351491328)
24. Firsova NV, Markintantova IuV, Smirnova IuA, Panova IG, Sukhikh GT, Zinov'eva RD, Mitashov VI. Identification of the OCT4-Pg1 retrogene and NANOG gene expression in the human embryonic eye. Biology Bulletin 2008;35(2):107-221.
25. Hochedlinger K, Yamada Y, Beard C, Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005;121(3):465-477. (Pubitemid 40692305)